A Blood Test to determine T2 risk

[skb]

A blood test could potentially be used to assess a patient's risk of type 2 diabetes, a new study from Edith Cowan University (ECU) has found.

The most commonly used inflammatory biomarker currently used to predict the risk of type 2 diabetes is high-sensitivity C-reactive protein (CRP). However, emerging research has suggested that the joint assessment of biomarkers, rather than assessing each individually, would improve the chances of predicting diabetes risk and diabetic complications.

A study by ECU researcher Dan Wu investigated the connection between systematic inflammation, assessed by joint cumulative high-sensitivity CRP and another biomarker called monocyte to high-density lipoprotein ratio (MHR), and incident type 2 diabetes.

Read More ...